Siemens CFO says perhaps last word not yet spoken on Swiss tariff row with US-February 2024-www.financetom.com

Siemens CFO says perhaps last word not yet spoken on Swiss tariff row with US

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

Siemens CFO says perhaps last word not yet spoken on Swiss tariff row with US

Aug 7, 2025 12:34 AM

BERLIN, Aug 7 (Reuters) - Siemens CFO Ralf Thomas said

on Thursday that "the last word has perhaps not yet been spoken"

on Switzerland's tariff row with the United States.

"There are always negotiations, sometimes even

renegotiations, and it would therefore be irresponsible to

immediately break out into major activities with every single

announcement on the subject," Thomas said during a news

conference on its quarterly results.

Previous page： Desktop Metal Sold! Nano Dimension Swoops In All-Cash Offer Next page： IntelGenx Details Preliminary Efficacy Results for Montelukast VersaFilm Clinical Trial in Patients with Alzheimer's Disease

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

Desktop Metal Sold! Nano Dimension Swoops In All-Cash Offer

Jul 3, 2024

Desktop Metal, Inc. ( DM ) shares are trading higher after it inked a definitive deal with Nano Dimension Ltd. ( NNDM ) , under which, Nano Dimension ( NNDM ) will fully acquire Desktop Metal ( DM ) in an all-cash deal at $5.50 per share. The deal offers a 27.3% premium over Desktop Metal’s closing price and a 20.5%...

IntelGenx Details Preliminary Efficacy Results for Montelukast VersaFilm Clinical Trial in Patients with Alzheimer's Disease

Jul 3, 2024

08:42 AM EDT, 07/03/2024 (MT Newswires) -- IntelGenx Technologies (IGX.TO) said Wednesday that its subsidiary IntelGenx completed the BUENA Alzheimer's disease (AD) study that used the Montelukast (MTK) drug. IntelGenx is repurposing MTK, a treatment for asthma and seasonal allergic rhinitis, to treat neuroinflammatory and neurodegenerative diseases. The study enrolled 59 adults with mild to moderate severity AD, of which...

Manchester United plans to cut 250 jobs, source says

Jul 3, 2024

By Yadarisa Shabong July 3 (Reuters) - Manchester United ( MANU ) is proposing to cut about 250 jobs as part of a club-wide redundancy programme, a source close to the company told Reuters. The job cuts would include all departments and levels of the club, except for its charitable arm Manchester United Foundation, according to the source. The job...

Grown Rogue Announced Secured Promissory Note to ABCO Garden State, LLC

Jul 3, 2024

08:36 AM EDT, 07/03/2024 (MT Newswires) -- Grown Rogue International Inc. ( GRUSF ) , a craft cannabis company, on Wednesday entered a secured drawdown promissory note agreement dated June 25, 2024, with ABCO Garden State, LLC , a New Jersey Class 1 licensed cultivator. As of the day and time of the release, Grown Rogue ( GRUSF ) owns...